A double-dichotomy clustering of dual pathology dementia patients

被引:5
作者
Caprihan, Arvind [1 ]
Raja, Rajikha [1 ,4 ]
Hillmer, Laura J. [2 ]
Erhardt, Erik Barry [3 ]
Prestopnik, Jill [2 ]
Thompson, Jeffrey [2 ]
Adair, John C. [2 ]
Knoefel, Janice E. [2 ]
Rosenberg, Gary A. [2 ]
机构
[1] Mind Res Network, Albuquerque, NM 87106 USA
[2] Univ New Mexico, Dept Neurol, Albuquerque, NM USA
[3] Univ New Mexico, Dept Math & Stat, Albuquerque, NM USA
[4] Univ Arkansas Med Sci, Dept Radiol, Little Rock, AR USA
来源
CEREBRAL CIRCULATION-COGNITION AND BEHAVIOR | 2021年 / 2卷
基金
美国国家卫生研究院;
关键词
Dual pathology dementia; Double-dichotomy clustering; White matter; Mean diffusivity; Amyloid; Phosphorylated Tau; SMALL VESSEL DISEASE; ALZHEIMERS-DISEASE; CEREBROVASCULAR-DISEASE; COGNITIVE IMPAIRMENT; DIAGNOSIS;
D O I
10.1016/j.cccb.2021.100011
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: Subcortical ischemic vascular disease (SIVD) and Alzheimer's disease (AD) related dementia can coexist in older subjects, leading to mixed dementia (MX). Identification of dementia sub-groups is important for designing proper treatment plans and clinical trials. Method: An Alzheimer's disease severity (ADS) score and a vascular disease severity (VDS) score are calculated from CSF and MRI biomarkers, respectively. These scores, being sensitive to different Alzheimer's and vascular disease processes are combined orthogonally in a double-dichotomy plot. This formed an objective basis for clustering the subjects into four groups, consisting of AD, SIVD, MX and leukoaraiosis (LA). The relationship of these four groups is examined with respect to cognitive assessments and clinical diagnosis. Results: Cluster analysis had at least 83% agreement with the clinical diagnosis for groups based either on Alzheimer's or on vascular sensitive biomarkers, and a combined agreement of 68.8% for clustering the four groups. The VDS score was correlated to executive function ( r =-0.28, p < 0.01) and the ADS score to memory function ( r = - 0.35, p < 0.002) after adjusting for age, sex, and education. In the subset of patients for which the cluster scores and clinical diagnoses agreed, the correlations were stronger (VDS score-executive function: r = - 0.37, p < 0.006 and ADS score-memory function: r = - 0.58, p < 0.0001). Conclusions: The double-dichotomy clustering based on imaging and fluid biomarkers offers an unbiased method for identifying mixed dementia patients and selecting better defined sub-groups. Differential correlations with neuropsychological tests support the hypothesis that the categories of dementia represent different etiologies.
引用
收藏
页数:10
相关论文
共 46 条
[1]   A Novel Imaging Marker for Small Vessel Disease Based on Skeletonization of White Matter Tracts and Diffusion Histograms [J].
Baykara, Ebru ;
Gesierich, Benno ;
Adam, Ruth ;
Tuladhar, Anil Man ;
Biesbroek, J. Matthijs ;
Koek, Huiberdina L. ;
Ropele, Stefan ;
Jouvent, Eric ;
Chabriat, Hugues ;
Ertl-Wagner, Birgit ;
Ewers, Michael ;
Schmidt, Reinhold ;
de Leeuw, Frank-Erik ;
Biessels, Geert Jan ;
Dichgans, Martin ;
Duering, Marco .
ANNALS OF NEUROLOGY, 2016, 80 (04) :581-592
[2]   Progression of MRI markers in cerebral small vessel disease: Sample size considerations for clinical trials [J].
Benjamin, Philip ;
Zeestraten, Eva ;
Lambert, Christian ;
Ster, Irina Chis ;
Williams, Owen A. ;
Lawrence, Andrew J. ;
Patel, Bhavini ;
MacKinnon, Andrew D. ;
Barrick, Thomas R. ;
Markus, Hugh S. .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2016, 36 (01) :228-240
[3]  
Brandt JBR, 2001, Hopkins verbal learning Test-Revised. Administration manual
[4]   Emerging Biomarkers in Vascular Cognitive Impairment and Dementia: From Pathophysiological Pathways to Clinical Application [J].
Cipollini, Virginia ;
Troili, Fernanda ;
Giubilei, Franco .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (11)
[5]   Cerebrospinal fluid biomarkers for understanding multiple aspects of Alzheimer's disease pathogenesis [J].
Dhiman, Kunal ;
Blennow, Kaj ;
Zetterberg, Henrik ;
Martins, Ralph N. ;
Gupta, Veer Bala .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2019, 76 (10) :1833-1863
[6]   Plasma biomarkers of astrocytic and neuronal dysfunction in early- and late-onset Alzheimer's [J].
Elahi, Fanny M. ;
Casaletto, Kaitlin B. ;
La Joiel, Renaud ;
Walters, Samantha M. ;
Harvey, Danielle ;
Wolf, Amy ;
Edwards, Lauren ;
Rivera-Contreras, Wilfredo ;
Karydas, Anna ;
Cobigo, Yann ;
Rosen, Howard J. ;
DeCarli, Charles ;
Miller, Bruce L. ;
Rabinovici, Gil D. ;
Kramer, Joel H. .
ALZHEIMERS & DEMENTIA, 2020, 16 (04) :681-695
[7]  
Erkinjuntti T, 2002, J NEURAL TRANSM-SUPP, P91
[8]   Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease [J].
Esiri, MM ;
Nagy, Z ;
Smith, MZ ;
Barnetson, L ;
Smith, AD .
LANCET, 1999, 354 (9182) :919-920
[9]   In search of multimodal brain alterations in Alzheimer's and Binswanger's disease [J].
Fu, Zening ;
Iraji, Armin ;
Caprihan, Arvind ;
Adair, John C. ;
Sui, Jing ;
Rosenberg, Gary A. ;
Calhoun, Vince D. .
NEUROIMAGE-CLINICAL, 2020, 26
[10]   Vascular Contributions to Cognitive Impairment and Dementia A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association [J].
Gorelick, Philip B. ;
Scuteri, Angelo ;
Black, Sandra E. ;
DeCarli, Charles ;
Greenberg, Steven M. ;
Iadecola, Costantino ;
Launer, Lenore J. ;
Laurent, Stephane ;
Lopez, Oscar L. ;
Nyenhuis, David ;
Petersen, Ronald C. ;
Schneider, Julie A. ;
Tzourio, Christophe ;
Arnett, Donna K. ;
Bennett, David A. ;
Chui, Helena C. ;
Higashida, Randall T. ;
Lindquist, Ruth ;
Nilsson, Peter M. ;
Roman, Gustavo C. ;
Sellke, Frank W. ;
Seshadri, Sudha .
STROKE, 2011, 42 (09) :2672-2713